GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: BMS-986205 | BMS986205 | Compound 2 [PMID: 29531094] | Example 19 [US20160137652A1]
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Linrodostat (BMS-986205) is a potent and selective, orally available  indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor [3], being investigated as an immuno-therapeutic for various malignancies. The INN for linrodostat specifies the (R) stereoisomer. The chemical structure is claimed as example 19 in Flexus Bioscience's patent US2016137652 [1] and the compound is being taken through clinical development by Bristol-Myers Squibb. Mechanistically, linrodostat competes with the heme cofactor for binding to the apo-form of the enzyme, and once bound prevents heme from rebinding [3].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Download 2D Structure  | |
| Canonical SMILES | Download | 
| Isomeric SMILES | Download | 
| InChI standard identifier | Download | 
| InChI standard key | Download | 
Molecular structure representations generated using Open Babel